Cargando…

Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet

Dietary fibre positively influences gut microbiome composition, enhancing the metabolism of dietary flavonoids to produce bioactive metabolites. These synergistic activities facilitate the beneficial effects of dietary flavonoids on cardiometabolic health parameters. The aims of this study were to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Si, Caparros-Martin, Jose A., Matthews, Vance B., Koch, Henrietta, O’Gara, Fergal, Croft, Kevin D., Ward, Natalie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031638/
https://www.ncbi.nlm.nih.gov/pubmed/29973701
http://dx.doi.org/10.1038/s41598-018-28521-8
_version_ 1783337349432737792
author Tan, Si
Caparros-Martin, Jose A.
Matthews, Vance B.
Koch, Henrietta
O’Gara, Fergal
Croft, Kevin D.
Ward, Natalie C.
author_facet Tan, Si
Caparros-Martin, Jose A.
Matthews, Vance B.
Koch, Henrietta
O’Gara, Fergal
Croft, Kevin D.
Ward, Natalie C.
author_sort Tan, Si
collection PubMed
description Dietary fibre positively influences gut microbiome composition, enhancing the metabolism of dietary flavonoids to produce bioactive metabolites. These synergistic activities facilitate the beneficial effects of dietary flavonoids on cardiometabolic health parameters. The aims of this study were to investigate whether isoquercetin (a major dietary flavonoid) and inulin (soluble fibre), either alone or in combination could improve features of the metabolic syndrome. Following a 1 week acclimatization, male C57BL6 mice (6–8 weeks) were randomly assigned to; (i) normal chow diet (n = 10), (ii) high fat (HF) diet (n = 10), (iii) HF diet + 0.05% isoquercetin (n = 10), (iv) HF diet + 5% inulin, or (v) HF diet + 0.05% isoquercetin + 5% inulin (n = 10). Body weight and food intake were measured weekly. At 12 weeks, glucose and insulin tolerance tests were performed, and blood, faecal samples, liver, skeletal muscle and adipose tissue were collected. At 12 weeks, mice on the HF diet had significantly elevated body weights as well as impaired glucose tolerance and insulin sensitivity compared to the normal chow mice. Supplementation with either isoquercetin or inulin had no effect, however mice receiving the combination had attenuated weight gain, improved glucose tolerance and insulin sensitivity, reduced hepatic lipid accumulation, adipocyte hypertrophy, circulating leptin and adipose FGF21 levels, compared to mice receiving the HF diet. Additionally, mice on the combination diet had improvements in the composition and functionality of their gut microbiome as well as production of short chain fatty acids. In conclusion, long-term supplementation with the dietary flavonoid isoquercetin and the soluble fibre inulin can attenuate development of the metabolic syndrome in mice fed a high fat diet. This protective effect appears to be mediated, in part, through beneficial changes to the microbiome.
format Online
Article
Text
id pubmed-6031638
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60316382018-07-12 Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet Tan, Si Caparros-Martin, Jose A. Matthews, Vance B. Koch, Henrietta O’Gara, Fergal Croft, Kevin D. Ward, Natalie C. Sci Rep Article Dietary fibre positively influences gut microbiome composition, enhancing the metabolism of dietary flavonoids to produce bioactive metabolites. These synergistic activities facilitate the beneficial effects of dietary flavonoids on cardiometabolic health parameters. The aims of this study were to investigate whether isoquercetin (a major dietary flavonoid) and inulin (soluble fibre), either alone or in combination could improve features of the metabolic syndrome. Following a 1 week acclimatization, male C57BL6 mice (6–8 weeks) were randomly assigned to; (i) normal chow diet (n = 10), (ii) high fat (HF) diet (n = 10), (iii) HF diet + 0.05% isoquercetin (n = 10), (iv) HF diet + 5% inulin, or (v) HF diet + 0.05% isoquercetin + 5% inulin (n = 10). Body weight and food intake were measured weekly. At 12 weeks, glucose and insulin tolerance tests were performed, and blood, faecal samples, liver, skeletal muscle and adipose tissue were collected. At 12 weeks, mice on the HF diet had significantly elevated body weights as well as impaired glucose tolerance and insulin sensitivity compared to the normal chow mice. Supplementation with either isoquercetin or inulin had no effect, however mice receiving the combination had attenuated weight gain, improved glucose tolerance and insulin sensitivity, reduced hepatic lipid accumulation, adipocyte hypertrophy, circulating leptin and adipose FGF21 levels, compared to mice receiving the HF diet. Additionally, mice on the combination diet had improvements in the composition and functionality of their gut microbiome as well as production of short chain fatty acids. In conclusion, long-term supplementation with the dietary flavonoid isoquercetin and the soluble fibre inulin can attenuate development of the metabolic syndrome in mice fed a high fat diet. This protective effect appears to be mediated, in part, through beneficial changes to the microbiome. Nature Publishing Group UK 2018-07-04 /pmc/articles/PMC6031638/ /pubmed/29973701 http://dx.doi.org/10.1038/s41598-018-28521-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Tan, Si
Caparros-Martin, Jose A.
Matthews, Vance B.
Koch, Henrietta
O’Gara, Fergal
Croft, Kevin D.
Ward, Natalie C.
Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet
title Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet
title_full Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet
title_fullStr Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet
title_full_unstemmed Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet
title_short Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet
title_sort isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031638/
https://www.ncbi.nlm.nih.gov/pubmed/29973701
http://dx.doi.org/10.1038/s41598-018-28521-8
work_keys_str_mv AT tansi isoquercetinandinulinsynergisticallymodulatethegutmicrobiometopreventdevelopmentofthemetabolicsyndromeinmicefedahighfatdiet
AT caparrosmartinjosea isoquercetinandinulinsynergisticallymodulatethegutmicrobiometopreventdevelopmentofthemetabolicsyndromeinmicefedahighfatdiet
AT matthewsvanceb isoquercetinandinulinsynergisticallymodulatethegutmicrobiometopreventdevelopmentofthemetabolicsyndromeinmicefedahighfatdiet
AT kochhenrietta isoquercetinandinulinsynergisticallymodulatethegutmicrobiometopreventdevelopmentofthemetabolicsyndromeinmicefedahighfatdiet
AT ogarafergal isoquercetinandinulinsynergisticallymodulatethegutmicrobiometopreventdevelopmentofthemetabolicsyndromeinmicefedahighfatdiet
AT croftkevind isoquercetinandinulinsynergisticallymodulatethegutmicrobiometopreventdevelopmentofthemetabolicsyndromeinmicefedahighfatdiet
AT wardnataliec isoquercetinandinulinsynergisticallymodulatethegutmicrobiometopreventdevelopmentofthemetabolicsyndromeinmicefedahighfatdiet